Introduction and application of CAS: 20977-05-3 | Sodium Aescinate
Sodium aescinate
Ingredients
The main ingredients of this product are sodium aescin A and sodium aescin B, which are triterpenoid saponins containing ester bonds extracted from the dried and mature seeds of the horse chestnut plant Tianshi Li.
use
An original drug with a national new compound patent (chemical structure patent), used for cerebral edema, swelling caused by trauma or surgery, and venous reflux disorders.
Pharmacological effects
This product can prompt the body to increase the plasma concentration of ACTH and cortisone, promote the blood vessel wall to increase the secretion of PGF2α, and scavenge free radicals in the body, thus acting as anti-inflammatory and anti-exudate, increasing venous tension, accelerating venous blood flow, and promoting Lymphatic reflux sends blood circulation and microcirculation, and protects blood vessel walls.
Specification of CAS: 20977-05-3 | Sodium Aescinate
|
ITEMS |
SPECIFICATION |
|
CAS |
20977-05-3 |
| MF | C53H82O36S4 |
|
MW |
0 |
| Melting Point | 250-252 °C |
|
Appearance |
Powder |
|
Purity |
99% |
| Solubility | ≥24.5mg/ml in DMSO |
|
Storage condition |
2-8°C |
| Production | China |
Package and transportation of CAS: 20977-05-3 | Sodium Aescinate
Package:1g, 10g, 25g 1kg
Transportation: by courier/ by air/ by sea
Hot Tags: cas: 20977-05-3 | sodium aescinate, China cas: 20977-05-3 | sodium aescinate manufacturers, factory, 4 5 Dimethyl 3 hydroxy 2 5 dihydrofuran 2 one, Phenylmethyl silicone oil, Cocamidopropyl hydroxysultaine, Tricobalt tetraoxide, Industrial Chemicals, TPS
